Mindblown: a blog about philosophy.
US approves $650 million missile sale to South Korea
WASHINGTON – The United States State Department has approved a potential military sale to the Republic of Korea, estimated at $650 million. This strategic deal includes 38 SM-6 Block I missiles along with a suite of supporting equipment and services. The Defense Security Cooperation Agency notified Congress of the proposed sale today, which aims to […]
Earnings call: Palatin reports Q1 FY2024 results, announces strategic partnerships, and reveals upcoming clinical trials
In its first quarter fiscal year 2024 earnings call, Palatin revealed robust growth in its Vyleesi product sales and net product revenue, as well as the announcement of strategic partnerships and upcoming clinical trials. The company also expressed confidence in achieving eight consecutive quarters of double-digit growth and discussed the progress of various programs, including […]
US approves $650 million missile sale to South Korea
WASHINGTON – The United States State Department has approved a potential military sale to the Republic of Korea, estimated at $650 million. This strategic deal includes 38 SM-6 Block I missiles along with a suite of supporting equipment and services. The Defense Security Cooperation Agency notified Congress of the proposed sale today, which aims to […]
Earnings call: Palatin reports Q1 FY2024 results, announces strategic partnerships, and reveals upcoming clinical trials
In its first quarter fiscal year 2024 earnings call, Palatin revealed robust growth in its Vyleesi product sales and net product revenue, as well as the announcement of strategic partnerships and upcoming clinical trials. The company also expressed confidence in achieving eight consecutive quarters of double-digit growth and discussed the progress of various programs, including […]
US approves $650 million missile sale to South Korea
WASHINGTON – The United States State Department has approved a potential military sale to the Republic of Korea, estimated at $650 million. This strategic deal includes 38 SM-6 Block I missiles along with a suite of supporting equipment and services. The Defense Security Cooperation Agency notified Congress of the proposed sale today, which aims to […]
Earnings call: Palatin reports Q1 FY2024 results, announces strategic partnerships, and reveals upcoming clinical trials
In its first quarter fiscal year 2024 earnings call, Palatin revealed robust growth in its Vyleesi product sales and net product revenue, as well as the announcement of strategic partnerships and upcoming clinical trials. The company also expressed confidence in achieving eight consecutive quarters of double-digit growth and discussed the progress of various programs, including […]
US approves $650 million missile sale to South Korea
WASHINGTON – The United States State Department has approved a potential military sale to the Republic of Korea, estimated at $650 million. This strategic deal includes 38 SM-6 Block I missiles along with a suite of supporting equipment and services. The Defense Security Cooperation Agency notified Congress of the proposed sale today, which aims to […]
Earnings call: Palatin reports Q1 FY2024 results, announces strategic partnerships, and reveals upcoming clinical trials
In its first quarter fiscal year 2024 earnings call, Palatin revealed robust growth in its Vyleesi product sales and net product revenue, as well as the announcement of strategic partnerships and upcoming clinical trials. The company also expressed confidence in achieving eight consecutive quarters of double-digit growth and discussed the progress of various programs, including […]
US approves $650 million missile sale to South Korea
WASHINGTON – The United States State Department has approved a potential military sale to the Republic of Korea, estimated at $650 million. This strategic deal includes 38 SM-6 Block I missiles along with a suite of supporting equipment and services. The Defense Security Cooperation Agency notified Congress of the proposed sale today, which aims to […]
Earnings call: Palatin reports Q1 FY2024 results, announces strategic partnerships, and reveals upcoming clinical trials
In its first quarter fiscal year 2024 earnings call, Palatin revealed robust growth in its Vyleesi product sales and net product revenue, as well as the announcement of strategic partnerships and upcoming clinical trials. The company also expressed confidence in achieving eight consecutive quarters of double-digit growth and discussed the progress of various programs, including […]
Got any book recommendations?